Alexander S Thomas
Examiner (ID: 8674, Phone: (571)272-1502 , Office: P/1783 )
Most Active Art Unit | 1783 |
Art Unit(s) | 1772, 1504, 1773, 1794, 1721, 1508, 1783, 1506, 2899, 1315 |
Total Applications | 3858 |
Issued Applications | 2891 |
Pending Applications | 154 |
Abandoned Applications | 575 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 4873655
[patent_doc_number] => 20080200389
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-08-21
[patent_title] => 'Rank-ligand-induced sodium/proton antiporter polypeptides'
[patent_app_type] => utility
[patent_app_number] => 12/082014
[patent_app_country] => US
[patent_app_date] => 2008-04-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 42526
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0200/20080200389.pdf
[firstpage_image] =>[orig_patent_app_number] => 12082014
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/082014 | Rank-ligand-induced sodium/proton antiporter polypeptides | Apr 6, 2008 | Abandoned |
Array
(
[id] => 5272478
[patent_doc_number] => 20090076254
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-03-19
[patent_title] => 'NON-ENDOGENOUS, CONSTITUTIVELY ACTIVATED HUMAN SEROTONIN RECEPTORS AND SMALL MOLECULE MODULATORS THEREOF'
[patent_app_type] => utility
[patent_app_number] => 12/051754
[patent_app_country] => US
[patent_app_date] => 2008-03-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 23985
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0076/20090076254.pdf
[firstpage_image] =>[orig_patent_app_number] => 12051754
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/051754 | Non-endogenous, constitutively activated human serotonin receptors and small molecule modulators thereof | Mar 18, 2008 | Issued |
Array
(
[id] => 5851159
[patent_doc_number] => 20060234350
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-10-19
[patent_title] => 'Endogenous and non-endogenous versions of human G protein-coupled receptors'
[patent_app_type] => utility
[patent_app_number] => 11/472717
[patent_app_country] => US
[patent_app_date] => 2006-06-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 17591
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0234/20060234350.pdf
[firstpage_image] =>[orig_patent_app_number] => 11472717
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/472717 | Endogenous and non-endogenous versions of human G protein-coupled receptors | Jun 21, 2006 | Abandoned |
Array
(
[id] => 5604265
[patent_doc_number] => 20060294612
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-12-28
[patent_title] => 'GPCR-LIKE RETINOIC ACID-INDUCED GENE 1 PROTEIN AND NUCLEIC ACID'
[patent_app_type] => utility
[patent_app_number] => 11/278477
[patent_app_country] => US
[patent_app_date] => 2006-04-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 39919
[patent_no_of_claims] => 40
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0294/20060294612.pdf
[firstpage_image] =>[orig_patent_app_number] => 11278477
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/278477 | GPCR-LIKE RETINOIC ACID-INDUCED GENE 1 PROTEIN AND NUCLEIC ACID | Apr 2, 2006 | Abandoned |
Array
(
[id] => 4995097
[patent_doc_number] => 20070010442
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-01-11
[patent_title] => 'Inhibitor of vascular endothelial cell growth factor'
[patent_app_type] => utility
[patent_app_number] => 11/375523
[patent_app_country] => US
[patent_app_date] => 2006-03-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 9673
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0010/20070010442.pdf
[firstpage_image] =>[orig_patent_app_number] => 11375523
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/375523 | Inhibitor of vascular endothelial cell growth factor | Mar 13, 2006 | Abandoned |
Array
(
[id] => 5028361
[patent_doc_number] => 20070269808
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-11-22
[patent_title] => 'Wnt receptor compositions and methods'
[patent_app_type] => utility
[patent_app_number] => 11/370191
[patent_app_country] => US
[patent_app_date] => 2006-03-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 8178
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0269/20070269808.pdf
[firstpage_image] =>[orig_patent_app_number] => 11370191
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/370191 | Wnt receptor compositions and methods | Mar 5, 2006 | Abandoned |
Array
(
[id] => 5851745
[patent_doc_number] => 20060234936
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-10-19
[patent_title] => 'Method for screening substances capable of inhibiting the hyperplasia of pancreatic cells and/or the hypersecretion of insulin by pancreatic cells'
[patent_app_type] => utility
[patent_app_number] => 11/362927
[patent_app_country] => US
[patent_app_date] => 2006-02-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 8585
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0234/20060234936.pdf
[firstpage_image] =>[orig_patent_app_number] => 11362927
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/362927 | Method for screening substances capable of inhibiting the hyperplasia of pancreatic cells and/or the hypersecretion of insulin by pancreatic cells | Feb 27, 2006 | Abandoned |
Array
(
[id] => 5655839
[patent_doc_number] => 20060141575
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-06-29
[patent_title] => 'Secreted proteins and nucleic acids encoding them'
[patent_app_type] => utility
[patent_app_number] => 11/354653
[patent_app_country] => US
[patent_app_date] => 2006-02-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 112
[patent_figures_cnt] => 112
[patent_no_of_words] => 36949
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0141/20060141575.pdf
[firstpage_image] =>[orig_patent_app_number] => 11354653
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/354653 | Secreted proteins and nucleic acids encoding them | Feb 14, 2006 | Abandoned |
Array
(
[id] => 5672094
[patent_doc_number] => 20060177448
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-08-10
[patent_title] => 'Inhibiting HER2 shedding with matrix metalloprotease antagonists'
[patent_app_type] => utility
[patent_app_number] => 11/351811
[patent_app_country] => US
[patent_app_date] => 2006-02-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 26647
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0177/20060177448.pdf
[firstpage_image] =>[orig_patent_app_number] => 11351811
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/351811 | Inhibiting HER2 shedding with matrix metalloprotease antagonists | Feb 8, 2006 | Abandoned |
Array
(
[id] => 252537
[patent_doc_number] => 07579169
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-08-25
[patent_title] => 'Hereditary hemochromatosis gene'
[patent_app_type] => utility
[patent_app_number] => 11/327689
[patent_app_country] => US
[patent_app_date] => 2006-01-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 22
[patent_no_of_words] => 31915
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 53
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/579/07579169.pdf
[firstpage_image] =>[orig_patent_app_number] => 11327689
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/327689 | Hereditary hemochromatosis gene | Jan 4, 2006 | Issued |
Array
(
[id] => 5619412
[patent_doc_number] => 20060188945
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-08-24
[patent_title] => 'Screening methods'
[patent_app_type] => utility
[patent_app_number] => 11/314257
[patent_app_country] => US
[patent_app_date] => 2005-12-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 4402
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0188/20060188945.pdf
[firstpage_image] =>[orig_patent_app_number] => 11314257
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/314257 | Screening methods | Dec 20, 2005 | Abandoned |
Array
(
[id] => 314528
[patent_doc_number] => 07524497
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-04-28
[patent_title] => 'Antibodies to PRO 1120 polypeptide'
[patent_app_type] => utility
[patent_app_number] => 11/290153
[patent_app_country] => US
[patent_app_date] => 2005-11-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 550
[patent_figures_cnt] => 550
[patent_no_of_words] => 58991
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 55
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/524/07524497.pdf
[firstpage_image] =>[orig_patent_app_number] => 11290153
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/290153 | Antibodies to PRO 1120 polypeptide | Nov 29, 2005 | Issued |
Array
(
[id] => 5694714
[patent_doc_number] => 20060154861
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-07-13
[patent_title] => 'Method for screening substances capable of inhibiting the hyperplasia of pancreatic cells and/or the hypersecretion of insulin by pancreatic cells'
[patent_app_type] => utility
[patent_app_number] => 11/257107
[patent_app_country] => US
[patent_app_date] => 2005-10-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 7095
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0154/20060154861.pdf
[firstpage_image] =>[orig_patent_app_number] => 11257107
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/257107 | Method for screening substances capable of inhibiting the hyperplasia of pancreatic cells and/or the hypersecretion of insulin by pancreatic cells | Oct 24, 2005 | Abandoned |
Array
(
[id] => 5651294
[patent_doc_number] => 20060137029
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-06-22
[patent_title] => 'Novel G protein-coupled receptor encoding gene and diagnostic uses therefor'
[patent_app_type] => utility
[patent_app_number] => 11/218716
[patent_app_country] => US
[patent_app_date] => 2005-09-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 18310
[patent_no_of_claims] => 46
[patent_no_of_ind_claims] => 15
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0137/20060137029.pdf
[firstpage_image] =>[orig_patent_app_number] => 11218716
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/218716 | Novel G protein-coupled receptor encoding gene and diagnostic uses therefor | Sep 5, 2005 | Abandoned |
Array
(
[id] => 5894404
[patent_doc_number] => 20060002943
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-01-05
[patent_title] => 'Compositions and methods for the treatment of tumor of hematopoietic origin'
[patent_app_type] => utility
[patent_app_number] => 11/142867
[patent_app_country] => US
[patent_app_date] => 2005-05-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 65969
[patent_no_of_claims] => 41
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0002/20060002943.pdf
[firstpage_image] =>[orig_patent_app_number] => 11142867
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/142867 | Compositions and methods for the treatment of tumor of hematopoietic origin | May 30, 2005 | Abandoned |
Array
(
[id] => 303730
[patent_doc_number] => 07534869
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-05-19
[patent_title] => 'Small and intermediate conductance, calcium-activated potassium channels and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 11/116760
[patent_app_country] => US
[patent_app_date] => 2005-04-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 33025
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 101
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/534/07534869.pdf
[firstpage_image] =>[orig_patent_app_number] => 11116760
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/116760 | Small and intermediate conductance, calcium-activated potassium channels and uses thereof | Apr 26, 2005 | Issued |
Array
(
[id] => 259872
[patent_doc_number] => 07572594
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-08-11
[patent_title] => 'Screening assays for agonists or antagonists or receptor activator of NF-κB'
[patent_app_type] => utility
[patent_app_number] => 11/099059
[patent_app_country] => US
[patent_app_date] => 2005-04-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18106
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 191
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/572/07572594.pdf
[firstpage_image] =>[orig_patent_app_number] => 11099059
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/099059 | Screening assays for agonists or antagonists or receptor activator of NF-κB | Apr 3, 2005 | Issued |
Array
(
[id] => 7136645
[patent_doc_number] => 20050181411
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-08-18
[patent_title] => 'Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 11/057169
[patent_app_country] => US
[patent_app_date] => 2005-02-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 37
[patent_figures_cnt] => 37
[patent_no_of_words] => 21864
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0181/20050181411.pdf
[firstpage_image] =>[orig_patent_app_number] => 11057169
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/057169 | Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof | Feb 14, 2005 | Abandoned |
Array
(
[id] => 7143910
[patent_doc_number] => 20050118635
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-06-02
[patent_title] => 'Secreted and transmembrane polypeptides and nucleic acids encoding the same'
[patent_app_type] => utility
[patent_app_number] => 11/040809
[patent_app_country] => US
[patent_app_date] => 2005-01-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 34029
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0118/20050118635.pdf
[firstpage_image] =>[orig_patent_app_number] => 11040809
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/040809 | Secreted and transmembrane polypeptides and nucleic acids encoding the same | Jan 20, 2005 | Abandoned |
Array
(
[id] => 7143910
[patent_doc_number] => 20050118635
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-06-02
[patent_title] => 'Secreted and transmembrane polypeptides and nucleic acids encoding the same'
[patent_app_type] => utility
[patent_app_number] => 11/040809
[patent_app_country] => US
[patent_app_date] => 2005-01-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 34029
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0118/20050118635.pdf
[firstpage_image] =>[orig_patent_app_number] => 11040809
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/040809 | Secreted and transmembrane polypeptides and nucleic acids encoding the same | Jan 20, 2005 | Abandoned |